New drug approved to fight ovarian cancer (Day 317)

Now that we are in the home stretch of my presidency, I thought I’d look a little closer to home for examples of chemical engineering success. IChemE’s Corporate Partners are a great place to start.

AstraZeneca, a multinational pharmaceutical company employing around 57,000 people worldwide, were awarded Silver Corporate Partner status in 2011.

woman with cancerThey are one of only a handful of companies involved in every aspect of pharmaceutical production from start to finish; from research to supply. So next time you pick up a prescription, there’s a good chance that AstraZeneca might have been involved.

One of their latest drugs to be approved is Lynparza, which is prescribed to patients who have been diagnosed with a mutated form of ovarian cancer.

Over 7,000 women in the UK are diagnosed with ovarian cancer every year. It’s the fifth most common cancer among women, mainly affecting the over 50’s – although it can affect women of any age.

Continue reading New drug approved to fight ovarian cancer (Day 317)